Back to Market Feed

CIMZIA 2X200 MG/ML(X3)START KT

certolizumab pegol
$6072.5100per EA

Strength

200 mg/mL

Manufacturer

UCB, Inc.

NDC

50474071081

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

CERTOLIZUMAB PEGOL

Approval Type

Biologic (BLA)

FDA Application

BLA125160

On Market Since

5/14/2009

Pharmacological Classes

Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+5.0%

3Y

N/A

5Y

N/A

All

+10.1%

Generic Alternatives

1 alternative • Same active ingredient

CIMZIA 2X200 MG/ML SYRINGE KIT
Brand
50474071079•UCB, Inc.
$6112.3912
+1% more

Related Drugs

Same classification

REMICADE 100 MG VIAL
Brand
57894003001•Janssen Biotech, Inc.
$1135.9660
per EA
ENBREL 25 MG/0.5 ML SYRINGE
Brand
58406001004•Immunex Corporation
$2076.2308
per ML
ENBREL 50 MG/ML SYRINGE
Brand
58406002104•Immunex Corporation
$2080.7423
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
Brand
58406004404•Immunex Corporation
$2081.5847
per ML
ENBREL 50 MG/ML SURECLICK
Brand
58406003204•Immunex Corporation
$2083.3498
per ML
SIMPONI 100 MG/ML PEN INJECTOR
Brand
57894007102•Janssen Biotech, Inc.
$7446.2126
per ML
SIMPONI 50 MG/0.5 ML PEN INJEC
Brand
57894007002•Janssen Biotech, Inc.
$12974.5178
per ML
SIMPONI 50 MG/0.5 ML SYRINGE
Brand
57894007001•Janssen Biotech, Inc.
$12977.2440
per ML